Rho differentially regulates the Hippo pathway by modulating the interaction between Amot and Nf2 in the blastocyst
Citations Over TimeTop 10% of 2017 papers
Abstract
The Hippo pathway modulates the transcriptional activity of Yap to regulate the differentiation of the inner cell mass (ICM) and the trophectoderm (TE) in blastocysts. Yet how Hippo signaling is differentially regulated in ICM and TE cells is poorly understood. Through an inhibitor/activator screen, we have identified Rho as a negative regulator of Hippo in TE cells, and PKA as a positive regulator of Hippo in ICM cells. We further elucidated a novel mechanism by which Rho suppresses Hippo, distinct from the prevailing view that Rho inhibits Hippo signaling through modulating cytoskeleton remodeling and/or cell polarity. Active Rho prevents the phosphorylation of Amot Ser176, thus stabilizing the interaction between Amot and F-actin, and restricting the binding between Amot and Nf2. Moreover, Rho attenuates the interaction between Amot and Nf2 by binding to the coiled-coil domain of Amot. By blocking the association of Nf2 and Amot, Rho suppresses Hippo in TE cells.
Related Papers
- → Polarity-Dependent Distribution of Angiomotin Localizes Hippo Signaling in Preimplantation Embryos(2013)428 cited
- → Roles and regulations of Hippo signaling during preimplantation mouse development(2016)97 cited
- → Par‐aPKC‐dependent and ‐independent mechanisms cooperatively control cell polarity, Hippo signaling, and cell positioning in 16‐cell stage mouse embryos(2015)78 cited
- → Position- and polarity-dependent Hippo signaling regulates cell fates in preimplantation mouse embryos(2015)72 cited
- → Position-Dependent Hippo Signaling Controls Cell Fates in Preimplantation Mouse Embryos(2014)1 cited